Clinical Learning Through Extended Immersion in Medical Simulation (CLEIMS)-A New Approach to Teaching Clinical Ethics

Study objective: This study is planning to develop a new simulation-based ethics education model and evaluate the effectiveness of the model to develop medical students' knowledge, moral reasoning, communication skills, and problem-solving abilities. Several strategies will be conducted to achieve this goal, including faculty development, ethics courses development, and case scenario development.

Methods: The transnational learning and workshops will be arranged for faculty to develop competence for simulation-based ethics education. The workshops will gather the interdisciplinary experts together to discuss and develop the core curriculum and case scenario. The students will be assigned randomly into the simulated clinical ethical situation with simulation patients for the intervention group, and into the workshop discussing clinical ethics case scenario for the control group. The instruments will be developed and the quantitative and qualitative analysis will be conducted.

Study Overview

Status

Recruiting

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

600

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Taiwan
      • Kaohsiung, Taiwan, Taiwan, 807
        • Recruiting
        • Kaohsiung Medical University Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • medical students in Kaohsiung Medical University
  • agree to participate the study

Exclusion Criteria:

  • disagree to participate

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: control group
workshop discussing the clinical ethical case scenario
Experimental: Intervention group
a simulated clinical ethical situation with simulation patients
participating a simulated clinical ethical situation with simulation patients

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Defining Issues Test (DIT) and self-developed questionnaire
Time Frame: through study completion, an average of 2 years
Defining Issues Test (DIT) and self-developed questionnaire for evaluation of moral reasoning
through study completion, an average of 2 years
ethical decision-making clinical examination
Time Frame: through study completion, an average of 2 years
clinical scenario exam designed for testing participants' ability of making ethical decision
through study completion, an average of 2 years
Problem Identification Test (PIT) and self-developed questionnaire
Time Frame: through study completion, an average of 2 years
Problem Identification Test (PIT) and self-developed questionnaire for evaluation of moral sensitivity
through study completion, an average of 2 years
knowledge test questionnaire
Time Frame: through study completion, an average of 2 years
questionnaire for ethics knowledge test
through study completion, an average of 2 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
results of Objective Structured Clinical Examination
Time Frame: through study completion, an average of 2 years
test score of Objective Structured Clinical Examination
through study completion, an average of 2 years
participant satisfaction questionnaire
Time Frame: through study completion, an average of 2 years
satisfaction questionnaire for participating the educational activities
through study completion, an average of 2 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 29, 2020

Primary Completion (Estimated)

July 31, 2026

Study Completion (Estimated)

July 31, 2026

Study Registration Dates

First Submitted

September 4, 2022

First Submitted That Met QC Criteria

September 18, 2022

First Posted (Actual)

September 21, 2022

Study Record Updates

Last Update Posted (Actual)

February 11, 2026

Last Update Submitted That Met QC Criteria

February 9, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • KMUHIRB-SV(II)-20200041

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Patient Simulation

Clinical Trials on simulation

Subscribe